Pernod Ricard (RI) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
15 Oct, 2026Executive summary
Q1 FY27 net sales were €2,234m, down 0.9% organically and 6.3% reported; performance improved sequentially in a volatile, uneven environment.
Volumes returned to growth at 6%, including 2% growth in Strategic International Brand volumes.
Sales declined in the U.S. and China amid inventory adjustments; India and other markets grew, and underlying China depletions returned to growth.
Financial highlights
Organic net sales declined 0.9% (€21m); reported sales fell 6.3% (€151m), including €127m perimeter impact and €3m FX impact.
Regional organic sales: Americas -9%, Asia / Rest of World +9%, Europe -6%.
Stable pricing and positive volume were offset by geographic mix, as higher-profit U.S. and China markets declined and India benefited from IPO-related pipe fill.
Outlook and guidance
FY27 organic net sales guidance remains broadly stable, with declines expected in the U.S. and China and positive Rest-of-World momentum, notably India.
Organic operating margin will be strongly defended through strict cost control and accelerated operational efficiencies; strategic investments are expected at c. €700m.
U.S. and China inventory adjustments are expected to ease from Q1 but continue through the year; China underlying trends are expected to improve.
FY27–29 organic sales growth target averages close to the lower end of the +3% to +6% range, with organic operating margin expansion expected.
Latest events from Pernod Ricard
- Organic net sales fell 3.9%, but cash flow and margins were strongly defended.RI
H2 2026 - Agile pricing, portfolio focus, and wholesaler realignment drive brand momentum and efficiency.RI
Investor Update - Distribution changes and data-driven strategies boost Power Six brands and RTD growth.RI
Investor update (Q&A) - Key brands outperform competitors as innovation and execution drive improved momentum.RI
Investor update - Q3 organic net sales rose 4.1%, but full-year sales are forecast to decline 3–4% amid FX headwinds.RI
Q3 2026 - Organic sales and profit declined, but free cash flow and debt metrics improved.RI
H1 2026 - Q1 organic sales fell 7.6%, but H2 is expected to improve as key markets recover.RI
Q1 2026 - Organic sales down 1%, margins up, net profit down 35%, FY25 growth expected.RI
H2 2024 - Q3 organic net sales fell 3%, but volumes rose and FY25 outlook and dividend were confirmed.RI
Q3 2025